Search

Researchers from Memorial Sloan Kettering Cancer Center (MSK) and their colleagues at the University of Pennsylvania (UPenn), in collaboration with the Parker Institute for Cancer Immunotherapy (PICI), studied changes in the blood of patients with stage IV melanoma who were all treated with the PD-1 drug pembrolizumab. Researchers looked at circulating immune cells called T cells that showed signs of being “reinvigorated” by the PD-1 therapy. For more information or to arrange interviews please e-mail Rebecca Williams at [email protected].

… Monday, April 10, 2017 Bottom Line :  Researchers from  Memorial Sloan Kettering Cancer Center  (MSK) and their colleagues at the University of Pennsylvania (UPenn), in collaboration with the Parker Institute for Cancer Immunotherapy (PICI), studied changes in the blood of patients with stage IV melanoma

Social worker Barbara Golby gives advice for restoring confidence, setting expectations, and disclosing disease history to cancer patients and survivors looking to jump into the dating scene.

… Thursday, February 11, 2016 Summary Having cancer or a history of the disease can make the search for a relationship seem intimidating. Social worker Barbara Golby gives advice for restoring confidence, setting expectations, and disclosing disease history and shares  resources for cancer patients and

After a relapse of sickle cell disease, Armani Rodriguez and his family found new hope and a special bond with Dr. Maria Cancio at MSK Kids.

… Tuesday, October 29, 2024 Armani Rodriguez was only 2 months old when he spent his very first Christmas in a hospital. Now 22 years old, the Brooklyn native can’t recall the searing pain that landed him there, but his mom will never forget. “He was always crying and needing pain medication,” says Awilda

Memorial Medical Care, PC, a practice of Memorial Sloan Kettering Cancer Center physicians, in collaboration with New York Cancer & Blood Specialists (NYCBS), recently announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn.

… Wednesday, January 4, 2023 New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn in collaboration with Memorial Medical Care, PC (MMC

The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s highest civilian honor — earlier this month.

… Wednesday, January 22, 2025 David M. Rubenstein The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s highest civilian honor — earlier this month. During a ceremony

A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy.

… Friday, March 1, 2019 A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy, according to our recent

Learn more about how MSK is developing new treatments for osteosarcoma and other bone cancers.

… Wednesday, September 14, 2016 Summary MSK is leading the way in osteosarcoma treatment, developing new surgical methods that enable many people to be cured and to live full, active lives. Highlights Osteosarcomas are rare tumors; two-thirds of them occur in children and young adults. They most frequently

Researchers from Memorial Sloan Kettering Cancer Center (MSK), in collaboration with an international research team, have discovered that DNA circles can contribute to the development of childhood cancers. The team, led by MSK computational biologist Richard Koche and Anton Henssen of Charité University Hospital Berlin, made this discovery by studying extrachromosomal DNA in neuroblastoma cells. Neuroblastoma develops in immature nerve cells and is the most common form of cancer in infants.

… Monday, December 16, 2019 Researchers from Memorial Sloan Kettering Cancer Center (MSK), in collaboration with an international research team, have discovered that DNA circles can contribute to the development of childhood cancers. The team, led by MSK computational biologist Richard Koche and Anton

An antibody test developed at MSK could shed light on the immune response to the COVID-19 virus.

… Tuesday, September 22, 2020 Summary A test developed by MSK researchers can detect three different antibodies to the COVID-19 virus. The test could help researchers clarify how someone fights off the virus, as well as who might be best protected if they are exposed a second time. Testing for antibodies

Blood pressure should be monitored closely and on an ongoing basis for several months after initiating ibrutinib treatment in patients with chronic lymphocytic leukemia (CLL), according to our retrospective study.

… Wednesday, January 8, 2020 Blood pressure should be monitored closely and on an ongoing basis for several months after initiating ibrutinib treatment in patients with chronic lymphocytic leukemia (CLL), according to our retrospective study published this month in JAMA Network Open . Hypertension is a